New hope through Ebola vaccine trial

December 23, 2014
Research and Development, Sales and Marketing Africa, Ebola, GAVI, GSK, US, marburg, uganda

A report in the Lancet medical journal has highlighted a treatment found to be well-tolerated in healthy Ugandan adults during …

lionel_goldfrank

New chairman for Egenix

December 23, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing egenix, lionel goldfrank

Lionel Goldfrank has been elected to sit on the board of the US-based biotech firm Egenix. Goldfrank is to succeed Donald …

Zerbaxa

Cubist boosts antibiotics market presence

December 22, 2014
Sales and Marketing Antibiotics, Zerbaxa, antimicrobial resistance, bacteria, cubist, infections, infectious diseases

Cubist has followed-up its successful European approval for a new antibiotic by winning an endorsement by the US FDA. The …

Cyramza

Lilly to market stomach cancer drug in Europe

December 22, 2014
Sales and Marketing Eli Lilly, Europe, FDA, US, cyramza, ramucirumab, stomach cancer

Eli Lilly has been granted permission by the European Commission to market Cyramza in Europe. Lilly’s Cyramza (ramucirumab) is the …

Abbvie

Abbvie Hep C drug gains FDA approval

December 22, 2014
Sales and Marketing AbbVie, FDA, Gilead, Viekira Pak, dasabuvir, harvoni, hepatitis, hepatits C

Abbvie has gained sign-off for its rival treatment to challenge Gileadโ€™s dominance of the growing market for new hepatitis C …

Chiesi gets first-ever European stem cell nod

December 19, 2014
Sales and Marketing Chiese, Chiesi, EMA, Holoclar, LSCD, MHRA, Stem cells, orexigen

Chiesi has received the first approval for an advanced therapy medicinal product containing stem cells for use in Europe. The …

Ian Goldin, director, Oxford Martin School, University of Oxford speaks at the c

Visions for the future: FT pharma and biotech event

December 19, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2020, ABPI, Deloitte, Medidata, Whitehead, financial ties, freeman, ft pharma

The FT Global Pharmaceutical and Biotechnology Conference held in London recently asked: โ€œWhat will the life science company of the …

Merck image

Merck acquires Swiss firm OncoEthix

December 19, 2014
Sales and Marketing Cancer, FDA, Merck, OTX015, cubist, keytruda, oncoethix, pembrolizumab

Hot on the heals of its Cubist buyout Merck has confirmed the acquisition of OncoEthix, a Swiss based firm which …

Roche image

Roche dealt with two late-stage blows

December 19, 2014
Sales and Marketing Alzheimer's, Alzheimerโ€™s, Cancer, Kadcyla, Perjeta, Roche, Xeloda, trastuzumab emtansine

Swiss giant Rocheโ€™s breast cancer treatment Kadcyla has failed to meet its primary endpoint and its investigational Alzheimerโ€™s treatment trial …

GSK image

GSK shingles vaccine on form

December 19, 2014
Sales and Marketing GSK, HZ/su, Merck, Vaccine, Zostavax, shingles

GlaxoSmithKline will be celebrating following the successful Phase III study of its shingles vaccine HZ/su that has met its primary …

NHS not au fait with mobile-savvy patients

December 19, 2014
Medical Communications, Sales and Marketing NHS, app, digital, health, mobile, smartphones, wearables

The NHS is failing to keep up with its digital generation of patients, a recent study has found.  Despite a …

andrew_plump_takeda

Takeda takes senior head from Sanofi

December 19, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, Takeda, andrew plump

Dr Andrew Plump will be joining Takeda in February from Sanofi to lead its global R&D operations as chief medical …

Pfizer image

New Lyrica formulation effective in trials

December 19, 2014
Sales and Marketing HIV, Lyrica, Pfizer, pain, pregabalin, shingles

Pfizer has reported positive Phase III results for a new formulation of its painkiller Lyrica. In the study, a controlled-release …

Humira biosimilar released in India

December 18, 2014
Research and Development, Sales and Marketing Humira, India, Zydus Cadila, anti-inflammatory, arthritis, bioscience

Indian firm Zydus Cadila has launched the first biosimilar of AbbVieโ€™s anti-inflammatory medicine Humira, the worldโ€™s biggest-selling drug. Used as …

Government plans ยฃ6 billion precision medicine strategy

December 18, 2014
Research and Development, Sales and Marketing ABPI, Cell Therapy Catapult, Ebola, George Osborne, UK, government

The government has committed to a ยฃ6 billion investment in scientific research and development as part of its science and …

Lundbeck scraps stroke drug

December 18, 2014
Research and Development, Sales and Marketing AIS, DIAS, Lundbeck, acute ischemic stroke, desmoteplase, stroke

Lundbeck has stopped development of its investigational stroke drug desmoteplase following disappointing results from its Phase III studies. The DIAS-3 …

Astrazeneca image

AstraZeneca ovarian cancer drug approved in Europe

December 18, 2014
Sales and Marketing AstraZeneca, BRCA, Cambridge, Cancer, FDA, lynparza, olaparib, ovarian

The European Commission has approved AstraZenecaโ€™s Lynparza for the treatment of advanced BRCA-mutated ovarian cancer. Lynparza (olaparib) has been approved …

bernard_poussot_roche

Roche adds two to its board

December 18, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bernard Poussot, Richard Lift, Roche, Sanofi

Roche intends to grow at its March annual general meeting via the election of Bernard Poussot and Richard Lift who …

Roche wins drug discovery award for Gazyvaro

December 18, 2014
Sales and Marketing BPS, British Pharmacological Society, GSK, Gazyvaro, Roche, mekinist

Roche has been named the winner of the 2015 Drug Discover of the Year award by the British Pharmacological Society …

Janssen Healthcare Innovation two-time finalists at eyeforpharma Barcelona Awards

December 17, 2014

Janssen Healthcare Innovationโ€™s Care4Today programme is set to take two of the highest honours at the 2015 eyeforpharma Barcelona Awards …

The Gateway to Local Adoption Series

Latest content